BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $19,291,000 | -26.4% | 411,595 | -4.3% | 0.17% | -21.5% |
| Q2 2021 | $26,220,000 | -9.6% | 430,115 | -8.6% | 0.21% | -13.7% |
| Q1 2021 | $28,995,000 | -32.8% | 470,700 | -22.4% | 0.25% | -29.1% |
| Q4 2020 | $43,147,000 | +77.9% | 606,760 | -6.1% | 0.35% | +54.2% |
| Q3 2020 | $24,254,000 | +3.5% | 646,430 | -10.0% | 0.23% | +1.3% |
| Q2 2020 | $23,434,000 | +65.7% | 718,629 | +47.4% | 0.22% | +32.5% |
| Q1 2020 | $14,142,000 | -18.6% | 487,650 | -1.6% | 0.17% | +9.0% |
| Q4 2019 | $17,369,000 | +50.3% | 495,550 | -7.9% | 0.16% | +52.0% |
| Q3 2019 | $11,558,000 | +185.7% | 538,330 | +258.9% | 0.10% | +229.0% |
| Q2 2019 | $4,046,000 | – | 150,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
| Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
| Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
| Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
| M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
| VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
| BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
| Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
| SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |